GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this offers value to shareholders.
ViiV Healthcare
Breaking News
- IBM's Acquisition of HashiCorp for $6.4 Billion Confirmed, Aimed at Strengthening Cloud Capabilities
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- TikTok Voluntarily Suspends New App's Task and Reward Program After EU Regulators Express Concern Over Addictive Effects Among Young Users
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- FAA Investigates Boeing’s Alleged Retaliation Against 2 Engineers Who Conveyed Safety Concerns in 2022
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Russia's Surprising Economic Strength to Last Another 18 Months Despite Western Sanctions and Ukraine War, Think Tank Says
- China Shows Heavy Support for Hong Kong Economy After Pressuring the Country to Enact New Security Law
